Sunday	(April 24, 1994) Panel Discussions
	Session I-‘Cost Containment in the Current (Regulatory) Environment’
	Joseph L. Waner, Oklahoma Children’s Memorial Hospital, Oklahoma City OK
	Gregory Storch, St. Louis Children’s Hospital, St. Louis MO
	Christine Robinson, Children’s Hospital, Denver CO
	Session II-‘Clinical Cases Presentation and Discussion’
	Richard Hodinka, Children’s Hospital of Philadelphia, Philadelphia PA
	Philip Hanff, Beth Israel Hospital, Boston MA
	James Overall, University of Utah College of Medicine, Salt Lake City UT
	Susan Coffin, Children’s Hospital of Philadelphia, Philadelphia PA
Day 1	(April 25, 1994) Session I-Clinical Aspects of Viral Diseases
	‘Hantaviruses: Pathogenesis and Diagnosis’
	Thomas Ksiazek, Centers for Disease Control, Atlanta GA
	‘Viruses in Troops Returning from Desert Wars: Lessons Learned’
	Mark Wallace, US Naval Hospital, San Diego CA
	‘Chlamydia pneumoniae: Is It a Significant Cause of Respiratory Disease?’
	LeeAnn Campbell, University of Washington, Seattle WA
	‘HHV-6: Disease and Pathogenesis’
	Richard Cone, University of Washington, Seattle WA
	‘Viruses and Mental Illness’
	Robert Yolken, The Johns Hopkins University School of Medicine, Baltimore MD
Day 2	(April 26, 1994) Session II-Diagnosis of Viral Infections
	‘Monitoring the Quality of Specimens’
	Ann Warford, Stanford University Hospital, Stanford CA
	‘Evolution of the Diagnostic Virology Laboratory’
	Edwin Lennette, California Public Health Foundation, Berkeley CA
	‘Practical Applications of Nucleic Acid Probes and PCR in the Diagnostic Virology Laboratory’
	Thomas Smith, Mayo Clinic and Foundation, Rochester MN
	‘Methods of Amplification (Other than PCR) for Detection of Viruses’
	Judith Wilber, Chiron Corporation, Emeryville CA
	Panel Discussion: Regulation and Licensing of Diagnostic Virology Laboratories
Day 3	(April 27, 1994) Session III-Prevention of and Therapy for Viral Infections
	‘Gene Therapy for HIV Infection: Progress and Prospects’
	Nava Sarver, National Institutes of Health, Bethesda MD
	‘Use of Cloned Patient CTL in Antiviral Therapy’
	Mark Gilbert, Fred Hutchinson Cancer Center, Seattle WA
	‘Chemotherapy for HIV and Drug Resistance’
	Richard D’Aquila, Massachusetts General Hospital, Boston MA
	‘Naked DNA Vaccines’
	Frederick Vogel, National Institutes of Health, Bethesda MD
	‘Subunit and Oral Vaccines for Respiratory Viruses’
	Richard Compans, Emory University School of Medicine, Atlanta, GA